Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?
- 14 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Journal of Autism and Developmental Disorders
- Vol. 51 (1), 371-376
- https://doi.org/10.1007/s10803-020-04531-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reportsBMC Psychiatry, 2015
- Neurodevelopmental delays and macrocephaly in 17p13.1 microduplication syndromeAmerican Journal of Medical Genetics Part A, 2014
- MutationTaster2: mutation prediction for the deep-sequencing ageNature Methods, 2014
- De novo duplication of 17p13.1-p13.2 in a patient with intellectual disability and obesityAmerican Journal of Medical Genetics Part A, 2014
- Glycines: Role in α-Helical Membrane Protein Structures and a Potential Indicator of Native ConformationBiochemistry, 2012
- 790 Kb microduplication in chromosome band 17p13.1 associated with intellectual disability, afebrile seizures, dysmorphic features, diabetes, and hypothyroidismEuropean Journal of Medical Genetics, 2012
- Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardationNature Genetics, 2010
- Autism Spectrum Disorders and Childhood-Onset Schizophrenia: Clinical and Biological Contributions to a Relation RevisitedJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patientsMolecular Psychiatry, 2004
- Catatonia and Autistic Spectrum DisordersAutism, 2004